BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 17939600)

  • 1. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
    Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C
    J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of resistant gestational trophoblastic tumors.
    Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
    Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
    Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
    Xiang Y; Sun Z; Wan X; Yang X
    J Reprod Med; 2004 Jun; 49(6):443-6. PubMed ID: 15283051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
    Cyriac S; Rajendranath R; Sridevi V; Sagar TG
    J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
    Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
    Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
    J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Wan XR; Sun ZJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gestational trophoblastic tumors and recent clinical information].
    Shimizu T; Yaegashi N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage chemotherapy for high-risk gestational trophoblastic tumor.
    Matsui H; Iitsuka Y; Suzuka K; Yamazawa K; Mitsuhashi A; Sekiya S
    J Reprod Med; 2004 Jun; 49(6):438-42. PubMed ID: 15283050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients with metastatic gestational trophoblastic tumor.
    Ghaemmaghami F; Behtash N; Soleimani K; Hanjani P
    Gynecol Oncol; 2004 Jul; 94(1):187-90. PubMed ID: 15262140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy after EMA/CO for gestational trophoblastic disease: a report from The Netherlands.
    Lok CA; van der Houwen C; ten Kate-Booij MJ; van Eijkeren MA; Ansink AC
    BJOG; 2003 Jun; 110(6):560-6. PubMed ID: 12798472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
    Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
    Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.